223 related articles for article (PubMed ID: 34567049)
1. Functional Characterization of Pembrolizumab Produced in
Phakham T; Bulaon CJI; Khorattanakulchai N; Shanmugaraj B; Buranapraditkun S; Boonkrai C; Sooksai S; Hirankarn N; Abe Y; Strasser R; Rattanapisit K; Phoolcharoen W
Front Plant Sci; 2021; 12():736299. PubMed ID: 34567049
[TBL] [Abstract][Full Text] [Related]
2. Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition.
Phetphoung T; Malla A; Rattanapisit K; Pisuttinusart N; Damrongyot N; Joyjamras K; Chanvorachote P; Phakham T; Wongtangprasert T; Strasser R; Chaotham C; Phoolcharoen W
PLoS One; 2022; 17(11):e0274737. PubMed ID: 36367857
[TBL] [Abstract][Full Text] [Related]
3. Molecular Farming of Pembrolizumab and Nivolumab.
Stark MC; Joubert AM; Visagie MH
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373192
[TBL] [Abstract][Full Text] [Related]
4. Biophysical and Immunological Characterization and
Hutchins B; Starling GC; McCoy MA; Herzyk D; Poulet FM; Dulos J; Liu L; Kang SP; Fayadat-Dilman L; Hsieh M; Andrews CL; Ayanoglu G; Cullen C; Malefyt RW; Kastelein RA; Saux SL; Lee J; Li S; Malashock D; Sadekova S; Soder G; van Eenennaam H; Willingham A; Yu Y; Streuli M; Carven GJ; van Elsas A
Mol Cancer Ther; 2020 Jun; 19(6):1298-1307. PubMed ID: 32229606
[TBL] [Abstract][Full Text] [Related]
5. Development of Plant-Derived Bispecific Monoclonal Antibody Targeting PD-L1 and CTLA-4 against Mouse Colorectal Cancer.
Bulaon CJI; Khorattanakulchai N; Rattanapisit K; Sun H; Pisuttinusart N; Phoolcharoen W
Planta Med; 2024 Apr; 90(4):305-315. PubMed ID: 38373705
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibodies B38 and H4 Produced in
Shanmugaraj B; Rattanapisit K; Manopwisedjaroen S; Thitithanyanont A; Phoolcharoen W
Front Plant Sci; 2020; 11():589995. PubMed ID: 33329653
[TBL] [Abstract][Full Text] [Related]
7. Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody.
Rattanapisit K; Phakham T; Buranapraditkun S; Siriwattananon K; Boonkrai C; Pisitkun T; Hirankarn N; Strasser R; Abe Y; Phoolcharoen W
Sci Rep; 2019 Oct; 9(1):15205. PubMed ID: 31645587
[TBL] [Abstract][Full Text] [Related]
8. Transient expression and purification of β-caryophyllene synthase in
Muthusamy S; Vetukuri RR; Lundgren A; Ganji S; Zhu LH; Brodelius PE; Kanagarajan S
PeerJ; 2020; 8():e8904. PubMed ID: 32377446
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation.
Roberts A; Bentley L; Tang T; Stewart F; Pallini C; Juvvanapudi J; Wallace GR; Cooper AJ; Scott A; Thickett D; Lugg ST; Bancroft H; Hemming B; Ferris C; Langman G; Robinson A; Chapman J; Naidu B; Pinkney T; Taylor GS; Brock K; Stamataki Z; Brady CA; Curnow SJ; Gordon J; Qureshi O; Barnes NM
Sci Rep; 2021 Feb; 11(1):4030. PubMed ID: 33597595
[TBL] [Abstract][Full Text] [Related]
10. Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in
Boonyayothin W; Sinnung S; Shanmugaraj B; Abe Y; Strasser R; Pavasant P; Phoolcharoen W
Front Plant Sci; 2021; 12():683417. PubMed ID: 34249053
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of plant-produced Nivolumab in transgenic C57BL/6-hPD-1 mouse implanted with MC38 colon cancer.
Bulaon CJI; Sun H; Malla A; Phoolcharoen W
Biotechnol Rep (Amst); 2023 Jun; 38():e00794. PubMed ID: 37064962
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.
Poulose JV; Kainickal CT
World J Clin Oncol; 2022 May; 13(5):388-411. PubMed ID: 35662989
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody.
Rattanapisit K; Bulaon CJI; Strasser R; Sun H; Phoolcharoen W
Sci Rep; 2023 Aug; 13(1):14146. PubMed ID: 37644118
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer.
Bulaon CJI; Khorattanakulchai N; Rattanapisit K; Sun H; Pisuttinusart N; Strasser R; Tanaka S; Soon-Shiong P; Phoolcharoen W
Front Plant Sci; 2023; 14():1149455. PubMed ID: 37711295
[TBL] [Abstract][Full Text] [Related]
15. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
[TBL] [Abstract][Full Text] [Related]
16. Keytruda and PD-L1: a Real-World Example of Co-development of a Drug with a Predictive Biomarker.
Emancipator K
AAPS J; 2020 Nov; 23(1):5. PubMed ID: 33222057
[TBL] [Abstract][Full Text] [Related]
17. Rapid transient expression of functional human vascular endothelial growth factor in
Bulaon CJI; Shanmugaraj B; Oo Y; Rattanapisit K; Chuanasa T; Chaotham C; Phoolcharoen W
Biotechnol Rep (Amst); 2020 Sep; 27():e00514. PubMed ID: 32884911
[TBL] [Abstract][Full Text] [Related]
18. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II-The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):26-34. PubMed ID: 29120224
[TBL] [Abstract][Full Text] [Related]
19. Expression optimization, purification and
Hanittinan O; Oo Y; Chaotham C; Rattanapisit K; Shanmugaraj B; Phoolcharoen W
Biotechnol Rep (Amst); 2020 Dec; 28():e00524. PubMed ID: 32953470
[TBL] [Abstract][Full Text] [Related]
20. PD-1/PD-L1 Checkpoint Inhibitors Are Active in the Chicken Embryo Model and Show Antitumor Efficacy
Wang Y; Rousset X; Prunier C; Garcia P; Dosda E; Leplus E; Viallet J
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
